Predictors of hypomagnesemia with denosumab in patients with metastatic bone disease from solid malignancies: A single-institution retrospective study,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(11/2023)
Status: Approved
Risk Factors of Hypomagnesemia in Patients with Bone Metastases from Solid Malignancies Treated with Zoledronic Acid: A Single-institution Retrospective Study,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(10/2024)
Status: Approved